Fig. 12

The prediction value of lncRNA risk groups for immunotherapy responses in TCGA cohort. A The high-risk group obtained significantly poorer immunotherapy response if no immunotherapy was performed (p < 0.001). B The high-risk group obtained significantly poorer immunotherapy response if only anti-PD1 immunotherapy was conducted (p < 0.001). C The high-risk group obtained significantly poorer immunotherapy response if only anti-CTLA4 immunotherapy was used (p < 0.001). D The high-risk group obtained significantly poorer immunotherapy response even though anti-PD1 and anti-CTLA4 immunotherapy methods were simultaneously conducted (p < 0.001)